Live

live biotherapeutics

2 articles

Seres Therapeutics Swings to $5.7M Profit on Nestlé VOWST Sale, Eyes 2026 Clinical Data

GlobeNewswire Inc.

GlobeNewswire Inc.·Mar 12·Seres Therapeutics, Inc.

Seres Therapeutics Swings to $5.7M Profit on Nestlé VOWST Sale, Eyes 2026 Clinical Data

Seres Therapeutics swung to $5.7M 2025 profit from $125.8M loss, boosted by Nestlé VOWST sale, with $45.8M cash funding ops through Q3 2026.

MCRBclinical trialinflammatory bowel disease

Human Microbiome Market Projected to Reach $3.27B by 2035

GlobeNewswire Inc.

GlobeNewswire Inc.·Feb 16·Researchandmarkets.Com

Human Microbiome Market Projected to Reach $3.27B by 2035

Human microbiome market expected to grow nearly fourfold to $3.27B by 2035, driven by advancing sequencing technology and 215+ therapeutic candidates in clinical development.

NSRGYMCRBclinical trialspersonalized medicine